Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Switch Symbol:
PB Ratio: Premium Valuation
Trending lower, above historical average, structural decline.
Left:
||||
Price-to-book ratio
Latest
1.94
↑ 114% above average
Average (9y)
-14.14
Historical baseline
Range
High:8.72
Low:-166.30
CAGR
-15.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 1.94 | -12.1% |
| 2023 | 2.21 | -7.0% |
| 2022 | 2.37 | +89.0% |
| 2021 | 1.26 | +157.5% |
| 2020 | 0.49 | -48.9% |
| 2019 | 0.95 | -45.3% |
| 2018 | 1.75 | -66.5% |
| 2017 | 5.21 | +103.1% |
| 2016 | -166.30 | -2006.8% |
| 2015 | 8.72 | - |